| answer text |
<p>In 2021, the UK was the third largest development donor in the G7 as a percentage
of GNI, spending over £11 billion on aid. The UK is committed to the global eradication
of antimicrobial resistance and supports a wide range of activities to do this.</p><p>
</p><p>Through our £265m ODA Fleming Fund, the UK builds partnerships with LMICs to
strengthen AMR surveillance, diagnostics and laboratory capacity. The Global AMR Innovation
Fund (GAMRIF), another UK aid fund, supports early-stage innovative research in underfunded
areas of AMR research and development for the benefit of people in low- and middle-income
countries.</p><p> </p><p>We have also used our aid budget to reduce the risks of antimicrobial
resistance by helping prevent the emergence and spread of infectious diseases. Between
April 2020 and December 2021, in partnership with Unilever the UK reached over 4 million
refugees and internally displaced persons (IDPs) with handwashing messages to prevent
the spread of infection in countries such as Bangladesh, Cameroon, Syria, South Sudan
and Yemen. The UK also supports the work of the United Nations High Commissioner for
Refugees, the International Organisation for Migration and the Red Cross Movement,
each of which include work on water, sanitation and hygiene as part of their programming
and support displaced persons, including refugees and migrants in camps.</p><p> </p>
|
|
